Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 54

    FIRST: Lupin launches Adhero, smart device to support treatment of respiratory disease in India

    FIRST: Lupin launches Adhero, smart device to support treatment of respiratory disease in India

    Farhat Nasim24 Nov 2019 10:15 AM IST
    Mumbai: Pharma major Lupin Limited (Lupin) recently announced the launch of “ADHERO,” a new connected smart device for metered-dose inhalers. This...
    AstraZeneca leukemia drug Calquence gets USFDA okay

    AstraZeneca leukemia drug Calquence gets USFDA okay

    Medical Dialogues Bureau24 Nov 2019 10:00 AM IST
    New Delhi: AstraZeneca said late on Thursday that the U.S. Food and Drug Administration (FDA) had given its go-ahead for the company's Calquence drug...
    CNS Pharma acquires worldwide rights for brain cancer drug Berubicin from Houston Pharma

    CNS Pharma acquires worldwide rights for brain cancer drug Berubicin from Houston Pharma

    Medical Dialogues Bureau24 Nov 2019 9:20 AM IST
    CNS Pharma intends to apply for orphan drug status for Berubicin with the FDA for the treatment of malignant glioma.New Delhi: CNS Pharmaceuticals, a...
    GE Healthcare gets USFDA clearance for deep learning-based CT image reconstruction technology

    GE Healthcare gets USFDA clearance for deep learning-based CT image reconstruction technology

    Medical Dialogues Bureau24 Nov 2019 9:17 AM IST
    New Delhi: GE Healthcare has received 510(k) clearance from the U.S. Food and Drug Administration of its Deep Learning Image Reconstruction engine on...
    Bristol Myers Opdivo-Yervoy combo misses main goal in late-stage skin cancer trial

    Bristol Myers Opdivo-Yervoy combo misses main goal in late-stage skin cancer trial

    Medical Dialogues Bureau24 Nov 2019 9:15 AM IST
    The trial was testing Bristol-Myers' drugs Opdivo and Yervoy, against Opdivo alone, in patients with advanced melanoma.New Delhi: Bristol-Myers Squibb...
    Lupin unveils generic version of Sun Pharma Westcort Cream to treat skin conditions

    Lupin unveils generic version of Sun Pharma Westcort Cream to treat skin conditions

    Medical Dialogues Bureau23 Nov 2019 1:14 PM IST
    Hydrocortisone Valerate Cream USP, 0.2%, is the generic equivalent of the Westcort Cream, 0.2%, of Sun Pharmaceutical Industries Inc., Lupin said.New...
    Alembic Pharma gets USFDA nod for generic version of Jadenu, Exjade tablet to treat chronic iron overload

    Alembic Pharma gets USFDA nod for generic version of Jadenu, Exjade tablet to treat chronic iron overload

    Farhat Nasim23 Nov 2019 12:34 PM IST
    Deferasirox tablets are generic versions of Novartis Pharmaceuticals Corporation’s Jadenu tablets and Exjade tablets for oral suspension in the same...
    Johnson and Johnson found negligent in landmark vaginal mesh lawsuit in Australia

    Johnson and Johnson found negligent in landmark vaginal mesh lawsuit in Australia

    Medical Dialogues Bureau23 Nov 2019 9:18 AM IST
    Australia's Federal Court found that Johnson and Johnson (JnJ) subsidiary Ethicon had sold the devices (pelvic mesh implants) without warning women...
    Bayer, WHO collaborate to combat taeniasis, neurocystercosis

    Bayer, WHO collaborate to combat taeniasis, neurocystercosis

    Medical Dialogues Bureau23 Nov 2019 9:17 AM IST
    With praziquantel (“Biltricide”) and niclosamide (“Yomesan”) Bayer will provide two effective treatments, which are part of the latest WHO Model List...
    Achillion Pharma PNH treatment Danicopan gets European Medicines Agency PRIME Designation

    Achillion Pharma PNH treatment Danicopan gets European Medicines Agency PRIME Designation

    Medical Dialogues Bureau23 Nov 2019 9:00 AM IST
    New Delhi: Achillion Pharmaceuticals, Inc. a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients and families...
    Chinese strategy: Dr Reddys outsources part manufacturing to local parties

    Chinese strategy: Dr Reddy's outsources part manufacturing to local parties

    Medical Dialogues Bureau22 Nov 2019 12:50 PM IST
    Hyderabad: Betting big on the Chinese market, Dr Reddy's Laboratories which has plans to launch over 70 products in the East Asian country has started...
    Cabinet nod to extension of pharmaceuticals purchase policy for pharma PSUs

    Cabinet nod to extension of pharmaceuticals purchase policy for pharma PSUs

    Medical Dialogues Bureau22 Nov 2019 12:28 PM IST
    New Delhi: The Union Cabinet on Wednesday approved the extension of Pharmaceuticals Purchase Policy (PPP) for pharmaceutical Central Public Sector...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Regulation of OTC drugs : CDSCO to soon amend Schedule K of Drugs and Cosmetics Act

    Regulation of OTC drugs : CDSCO to soon amend Schedule K of Drugs and Cosmetics Act

    Onco.com, dedicated cancer care platform, raises $7 million in Series A funding

    Onco.com, dedicated cancer care platform, raises $7 million in Series A funding

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok